Unusual endoscopic findings of CMV esophagitis after liver transplantation

Hepato-Gastroenterology

Volumn 52, Issue 64, 2005, Pages 1236-1239

  Harada, Noboru ^a   Shimada, Mitsuo ^a   Suehiro, Taketoshi ^a   Soejima, Yuji ^a   Ninomiya, Mizuki ^a   Shiotani, Satoko ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CMV; Esophagitis; Living donor liver transplantation

Indexed keywords

GANCICLOVIR; HYPERIMMUNE GLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS ESOPHAGITIS; CYTOMEGALOVIRUS INFECTION; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS BIOPSY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; MALE; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CYTOMEGALOVIRUS INFECTIONS; ESOPHAGITIS; ESOPHAGOSCOPY; GANCICLOVIR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 21744452116     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Shepp DH, Dandlikes PS, de Miranda P, et al: Activity of 9-[2-hydroxy-1-(hydrokymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia. Ann Intern Med 1985; 103:368.
2. Fulginiti VA, Scribner R, Groth CG, et al: Infections in recipients of liver homografts. N Engl J Med 1968; 279:619.
3. Betts RF, Hanshaw JB: Cytomegalovirus (CMV) in the compromised host(s). Annu Rev Med 1977; 28:103.
4. Ho M, Wajszczuk CP. Hardy A, et al: Infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplant Proceed 1983; 15:2768.
5. Wien M, Schmidt CA, Lohmann R, et al: Cytomegalovirus disease after liver transplantation:Diagnostic and therapy. Transplant Proceed 1993; 25:2673.
6. Stein DS, Verano AS, Levandowski RA: Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation. Am J Gastroenterol 1988; 83:684.
7. Alexander JA, Brouillette DE, Chien MC, Yoo YK, Tarter RE, Gavaier JS, Van Thiel: Infectious esophagitis following liver and renal transplantation. Dig Dis Sci 1988; 34:92.
8. Harbison MA, De Girolami PC, Jenkins RL, Hammer SM: Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation 1988; 46:82.
9. Collaborative DHPG treatment study group: Treatment of cytomegalovirus infections with 9-[2-hydroxy-1-(hydro-kymethyl)ethoxymethyl]guanine in patients with AIDS and other immunodeficiencies. N Eng J Med 1986; 314:801.
10. Felsenstein D, D'Amico DJ, Hirsch MS, et al: Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydrokymethyl) ethoxymethyl]guanine. Ann Intern Med 1985; 103:377.
11. Bach MC, Bagwell SP, Knapp NP, et al: 9-[2-hydroxy-1-(hydrokymethyl) ethoxymethyl] guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103:381.
12. Mitras FA: Inflammatory and neoplastic diseases of the esophagus. In: Applebaum HD (Ed.). Pathology of the esophagus, stomach, and duodenum. New York: Churchill-Livingstone, 1979.
13. Stein DS, Verano AS, Levandowski RA et al: Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation. Am J Gastroenterol 1988; 83:684.
14. Sayage LH, Gonwa TA, Goldstein RM, et al: Cytomegalovirus-6 infection in orthotopic liver transplantation. Transpl Int 1989; 2:96.
15. Alexander JA, Brouillette DE, Van Thiel DH, et al: Infectious esophagitis following liver and renal transplantaion. Dig Dis Sci 1988; 33:1121.
16. Hadley S, Samore MH, Hammer SM, et al: Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or PK506 as primary immunosuppression. Transplantation 1995; 59:851.
17. David L, Paterson, Nina Singh, Ignazio R, Marino et al: Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. Transplantation 1998; 66:593.